How is the Ovarian Cancer Diagnostics Market Poised for Growth: Trends and Opportunities Through 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the ovarian cancer diagnostics market size evolved in recent years?
In previous years, the ovarian cancer diagnostics market size has exhibited strong growth. The market is set to expand from $2.74 billion in 2024 to $2.92 billion in 2025, with a compound annual growth rate (CAGR) of 6.6%. This notable growth over the historic period can be traced back to factors such as the development and validation of biomarkers, the widespread adoption of transvaginal ultrasound technology, increased awareness of BRCA gene mutations, research into tumor markers, and the implementation of screening programs and guidelines.
What are the predictions for the ovarian cancer diagnostics market size in the coming years?
In the forthcoming years, a substantial increase is anticipated in the market size of ovarian cancer diagnostics, reaching $3.93 billion by 2029 with a compound annual growth rate (CAGR) of 7.6%. The expansion during this forecast period can be associated with elements such as initiatives for early diagnosis, rising occurrences of ovarian cancer, the implementation of artificial intelligence (AI), personalized treatment strategies, the introduction of innovative biomarkers, as well as genomic and proteomic profiling. Key trends expected to be seen during the forecast period are the incorporation of biosensor technologies for early detection, integration of digital pathology, advancements in imaging modalities, enhanced imaging technologies, and progressions in pathology techniques.
Get your ovarian cancer diagnostics market report here!
https://www.thebusinessresearchcompany.com/report/ovarian-cancer-diagnostics-global-market-report
What key factors are fueling the growth of the ovarian cancer diagnostics market?
The growing incidence of ovarian cancer is predicted to spur the expansion of the ovarian cancer diagnostics market in the future. Ovarian cancer, a malignant tumor that forms in the ovaries – the female reproductive organs that produce eggs and hormones, has seen a surge due to longer life spans, postponed childbearing, and alterations in lifestyle. The prevalence of ovarian cancer could be curtailed with the aid of ovarian cancer diagnostics that facilitate early discovery and intervention, thus leading to prompt treatment and enhanced outcomes. For example, the World Ovarian Cancer, a Canada-based entity dedicated to raising awareness for women worldwide affected by ovarian cancer, predicted in 2022 that by 2050, the worldwide occurrence of ovarian cancer amongst women will grow over 55%, culminating in around 503,448 cases. Moreover, the yearly fatalities from ovarian cancer are expected to climb to 350,956, denoting nearly a 70% rise relative to 2022. Hence, this increasing incidence of ovarian cancer is fueling the progression of the ovarian cancer diagnosis market.
How is the global ovarian cancer diagnostics market divided into key segments?
The ovarian cancer diagnostics market covered in this report is segmented –
1) By Product Type: Instruments, Kits, Reagents
2) By Diagnosis Type: Biopsy, Blood Test, Imaging, Other Diagnosis Types
3) By Cancer Type: Epithelial Tumor, Germ Cell Tumor, Stromal Cell Tumor, Other Cancer Types
4) By End User: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes
Subsegments:
1) By Instruments: Imaging Systems, Biopsy Devices, Molecular Diagnostic Instruments
2) By Kits: Diagnostic Test Kits, Screening Kits
3) By Reagents: Antibodies, Enzymes, Assay Reagents
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12022&type=smp
Who are the key firms paving the way for growth in the ovarian cancer diagnostics market?
Major companies operating in the ovarian cancer diagnostics market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, GE HealthCare Technologies Inc., Quest Diagnostics Incorporated, Agilent Technologies Inc., Hologic Inc., Illumina Inc., PerkinElmer Inc., Sysmex Corporation, Bio-rad Laboratories Inc., Qiagen N.V., Natera Inc., Myriad Genetics Inc., ArcherDX Inc., Invitae Corporation, Guardant Health, Luminex Corporation, NanoString Technologies Inc., Siemens Healthcare Private Limited, Menarini Silicon Biosystems S.p.A., Precipio Inc., Angle plc
Which trends are expected to transform the ovarian cancer diagnostics market?
The increasing popularity of advanced diagnostic technology is a significant trend within the ovarian cancer diagnostics market. In order to maintain a competitive edge, companies within the ovarian cancer diagnostic market are leveraging these innovative technologies. As an example, Hoffmann-La Roche AG, a healthcare and pharmaceutical firm based in Switzerland, was granted FDA approval for the VENTANA FOLR1 (FOLR1-2.1) RxDx Assay in November 2022. This kit, which represents the first immunohistochemistry-based companion diagnostic test for identifying ovarian cancer patients eligible for the ELAHERE prescription medication, has been specially developed to offer crucial perspectives and detailed clinical data about ovarian cancer. This, in turn, enables better disease control and enhances patient outcomes.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12022
What regions are contributing significantly to the growth of the ovarian cancer diagnostics market?
North America was the largest region in the ovarian cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ovarian cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Microbiology Diagnostic Devices And Equipment Global Market Report 2024
Medical Equipment Maintenance Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/medical-equipment-maintenance-global-market-report
Point-of-Care Diagnostics Devices And Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
